Trial Profile
A real world study comparing bivalirudin and unfractionated heparin monotherapy in patients undergoing percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2017
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Acute coronary syndromes
- Focus Adverse reactions
- 14 Jul 2017 New trial record